The results of our studies showed, 1) depletion of >80% of Tm-Tn from myofibrils resulted in complete loss of the Ca 2+ regulated ATPase activity, and a significant loss in the maximal ATPase activity; 2) reconstitution of exogenous wild-type Tm-Tn resulted in complete regain in the calcium regulation, and in the maximal ATPase activity; 3) all HCM-associated Tm mutations increased the Ca 2+ sensitivity of ATPase activity and all had decreased abilities to inhibit ATPase activity. In contrast, the DCM-associated mutations both decreased the Ca 2+ sensitivity of ATPase activity, and had no effect on the inhibition of ATPase activity. These findings have demonstrated that the mutations which cause HCM and DCM disrupt discrete mechanisms, which may culminate in the distinct cardiomyopathic phenotypes.
Cardiac muscle contraction is initiated by an increase in the intracellular Ca 2+ concentration, where Ca 2+ binds to troponin (Tn) 1 , one of the regulatory proteins of muscle, inducing conformational changes in Tn, which further induces the movement of tropomyosin (Tm), another regulatory protein present in the thin filament.
This Tn-regulated cooperative movement of Tm during contraction and relaxation is thought to occur via a multiple-state conformational change, directly regulating the availability of actin for myosin binding (1) . Due to the cooperative nature of contractile protein function, an alteration in any one of the sarcomeric proteins could cause cardiac dysfunction, such as those found in patients suffering from hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM).
HCM is a disease of the heart, characterized by unexplained cardiac hypertrophy, myocyte disarray, and fibrosis. Considered a disease of the sarcomere, HCM is caused by hundreds of mutations in the genes encoding major cardiac contractile proteins (2) . Currently, eight mutations in α-Tm have been implicated in the pathogenesis of HCM including L185R and E62Q (3) .
The L185R mutation was first identified in an 8-year-old girl, whose sudden death and subsequent investigation lead to the discovery of a novel HCM-associated Tm mutation (4) , which seems to have arisen de novo in her father. This malignant mutation also caused the death of her younger brother at age 6. The E62Q mutation was also identified by investigation of the family members of a childhood sudden death victim (5) . In that family, all of the children who carried the mutation (4 out of 5), died before reaching the age of 20. Both HCM-associated Tm mutations are unique, not only because of the severe phenotype, but due to their positions in the Tm molecule. These two mutations lie in the outer-most regions of the coiled-coil structure, where they do not have any interactions in the Tm dimer, unlike the other HCM-causing mutations which are located in the Tm dimer interface where they participate in the stabilization of the Tm molecule through hydrophobic or electrostatic interactions.
DCM is a disease of the heart, characterized by dilatation and impaired contraction of the left or both ventricles. Autosomal dominant DCM is the most common heritable form and accounts for 56% of all familial DCMs (6) . DCM mutations have been found in the genes encoding cardiac cytoskeletal proteins as well as the genes encoding sarcomeric proteins, such as myosin heavy chain, myosin binding protein C, Tn, and Tm (7, 8) . In Tm, only two DCM-susceptibility mutations have been identified, E40K and E54K (8) . The E40K mutation was identified in a child who was diagnosed with DCM at three months of age. Aggressive medical intervention kept her alive long enough for a heart transplant at age 10. The E54K mutation was identified in a young man with a family history of heart failure. He was diagnosed with DCM at age 26, and died a year later, despite aggressive medical therapy and implantation of a defibrillator.
Although identified in two clinically different diseases, all four of these new cardiomyopathic mutations cause an increase in net positive charge on the surface of Tm, which may contribute to severe forms of cardiomyopathies (8) . Aside from being located in the troponin T (TnT) binding region, L185R is located right next to Serine 186, an amino acid identified to be least stable for the α-helical structure in that particular position (9) . The E62Q, E40K, and E54K mutations lie near several other HCM mutations and the recently characterized Alanine-rich region (10) , whose flexible sequence is essential for Actin binding.
Several decades ago, Perry and others reported the use of mild alkaline solutions to deplete native Tm from myofibrils, and also to produce modified or desensitized actomyosin preparations (11) (12) (13) (14) . In an attempt to extract all proteins from myofibrils, Perry found that the total amount of protein extracted, increased with the alkalinity of the buffers used, but not for actin (12) . Kominz et al later reported the use of sodiumcarbonate/bicarbonate buffers to remove Tm from actomyosin preparations (11) . The use of this particular method to deplete endogenous Tm and the Tn complex (Tm-Tn) from myofibrils has never been reported.
Here, we report for the first time, 1) the successful depletion of Tm-Tn from myofibrils, 2) the near complete reconstitution of exogenous Tm-Tn, and 3) the use of myofibrillar ATPase activity assays to investigate the functional consequences of these HCM-and DCM-associated Tm mutations, using this new preparation. All mutant and wild-type Tms used in this study, were bacterially expressed, with the Alanine-Serine extension to the amino-terminus to mimic acetylation (15) . Wild-type Tm with the AlanineSerine extension (ASWT) was selected over the wild-type Tm without the extension (WT), based on previous reports (15) , and reconstitution experiments conducted in this study ( Figure 5 ).
The results of the present study have shown that depletion of >80% of Tm-Tn from myofibrils resulted in complete loss of the Ca 2+ regulated ATPase activity, and a significant loss in the maximal ATPase activity. The reconstitution of exogenous ASWT Tm-Tn restored the regulatory activity and the maximal ATPase activity at high [Ca 2+ ]. The Ca 2+ sensitivities of the ATPase activity measurements were increased by all HCM-causing mutations, and all mutants showed decreased ability to inhibit ATPase activity at low [Ca 2+ ]. The DCM-associated Tm mutations: E40K and E54K, both decreased the Ca 2+ sensitivity of ATPase activity. In contrast to the HCM mutants, the DCM mutants did not affect the inhibition of ATPase activity. Furthermore, in light of the novel results which show the loss of inhibition in HCM Tm mutants, this method may be more sensitive than reconstituted actomyosin ATPase assays. These findings have demonstrated that the Tm mutations which cause HCM and DCM disrupt discrete mechanisms, which may explain the manifestation of divergent cardiomyopathic phenotypes.
EXPERIMENTAL PROCEDURES

Expression and Purification of Recombinant Tms and Tns
Human cardiac α-Tm cDNA was amplified by RT-PCR of human heart mRNA. Verified full length cardiac Tm cDNA was then cloned into the pET3d vector for protein expression. Mutant Tms were obtained by a primer directed PCR method, and successful mutagenesis was confirmed by sequencing.
Tms were purified utilizing a previously described method (16) , but with steeper elution gradients. Briefly, bacterially expressed and extracted Tms were purified on a DE-52 column. Tm was eluted with a KCl gradient, and the semi-purified Tm was then further purified on a HA column at room temperature. Pure Tm was eluted with a sodium phosphate gradient. All steps were performed at 4˚C except the HA column chromatography. The >95% purity of the isolated Tms was determined by SDS-PAGE. Human cardiac Troponin T (TnT), Troponin I (TnI), and Troponin C (TnC), were all bacterially expressed and purified separately by standard methods routinely used in this laboratory (17) (18) (19) . Human cardiac Tn complexes comprised of recombinant TnT, TnI, and TnC, was prepared by sequential dialysis in decreasing concentrations of urea, as routinely done in the lab (20) .
Myofibril Sample Preparation for ATPase Assay
A) Depletion of endogenous Tm-Tn from porcine cardiac myofibrils Porcine cardiac myofibrils (PCM) were prepared from left ventricles, by Triton X-100 treatments as previously described by Solaro et al (21) . Myofibril preparations stored in 50% glycerol in -20°C, were first washed to remove the glycerol, by resuspension in ice cold wash buffer (60mM KCl, 10mM MOPS, 1mM DTT, pH 7.1) to approximately 3mg/mL, in a 30mL Corex open top glass tube. Myofibrils were spun down at 750 x g for 6 minutes at 4°C, and the supernatant containing glycerol and wash buffer was suctioned and collected in a vacuum trap to minimize myofibril loss. Washed myofibrils were then depleted of its endogenous Tm and Tn by repetitive resuspension to approximately 2mg/mL in depletion buffer (2mM sodium carbonate/bicarbonate buffer pH 9.0), and centrifugation ( Figure 4 ). All buffers used in depletion were chilled on ice prior to and during the depletion steps. Depletion washes cause swelling of the myofibrils, which is clearly visible in the transparency and volume change in the myofibrils, with each successive wash. A small percentage of non-depleting "clumpy" myofibrils are sometimes present, and can be identified by the differences in transparency. These clumpy myofibrils are left in the depleted sample mixture because it represents a very small fraction of the total depleted myofibril.
B) Reconstitution of Tm-Tn into depleted myofibrils
Depleted myofibrils (DM) were resuspended to approximately 5mg/mL in reconstitution buffer (120mM KCl, 10mM MOPS pH 7.0, 7mM MgCl 2 , 6mM EGTA, 1mM DTT, and 5mM K 2 ATP), spun down, and resuspended in reconstitution buffer again, to ensure that most of the depletion buffer had been removed. Exogenous Tms and Tns which had been separately pre-dialyzed into reconstitution buffer were prepared for reconstitution by mixing in equimolar concentrations, 30 minutes prior to the reconstitution procedure. Five mgs of depleted myofibrils were reconstituted with exogenous TmTn by incubation with 4.5µM Tm-Tn in 2mL lowadhesion microcentrifuge tubes ( Figure 4 ). Molecular weights used for concentration calculations are: 65733.4 (ASWT), 65417 (WT), 65731.4 (E40K, E54K, E62Q), 65588 (E180G), 65819.4 (L185R), 76751.4 (Tn complex). The myofibril and protein mixture of 2mL final volume in 2mL microcentrifuge tubes, were incubated for 1 hour in a 4°C cold room, while rotating, to reduce settling out of the myofibrils.
After the one hour, myofibrils were spun down, supernatant removed, and washed 1x in wash buffer to remove excess Tm-Tn, then gently resuspended again in the wash buffer to >2.5mg/mL concentration, for use in ATPase activity assay. Myofibril concentrations were determined by the Bradford assay with bovine serum albumin as a standard, utilizing the Coomassie Plus Protein Assay Reagent (Pierce).
Myofibrillar ATPase Activity Assay
Myofibrillar ATPase activity assays were performed as previously described (22), with the following modifications. Assay sample tubes comprised of equal total concentration of myofibrils (100µL myofibril volume), and various Ca 2+ buffers at the final volume of 0.975mL were pre-incubated for exactly 5 minutes in a 30°C water bath, and the reaction was started with 25µL of 100mM K 2 ATP. The ATPase reaction rate was optimized to be linear between 10 to 15 minutes, so 12 minutes of incubation at 30°C was used, and the reaction was stopped with 200µL of 30% trichloroacetic acid.
Maximal Electrophoresis SDS-PAGE was performed according to the procedure of Laemmli (23) . For all densitometric analyses, approximately 10µg of myofibril samples were loaded into 12.5% SDSpolyacrylamide gels.
After electrophoretic separation, the gels were stained with Coomassie Brilliant Blue and gel band densitometry was measured using Scion gel analysis software.
RESULTS
Method for Depletion of the Endogenous Tm-Tn
Complex-In order to determine the effects of removal of endogenous Tm-Tn from myofibrils and to optimize the conditions for maximal depletion, myofibrils were washed in depletion buffer numerous times, and the effects of the washes on maximal activity and inhibition were investigated. Figure 1 shows the ATPase activity of PCM washed multiple times, ranging from 5 to 13 washes, assayed in the presence or absence of Ca 2+ . In comparison to undepleted PCM, the ATPase activity in the presence of Ca 2+ decreased after 10 washes, while the ATPase activity in the absence of Ca 2+ comparatively increased, suggesting an increase in the amount of regulatory units being removed from the myofibrils. The ATPase activity at high [Ca 2+ ] is 81 ± 5.8% (n=3) of PCM for myofibrils which had been washed 8 times, and is only 63 ± 7.6% (n=5) for myofibrils which had been washed 13 times. The net regulated activity was measured to be 96 ± 4.6% (n=7) for PCM, 11 ± 1.5% (n=3) for 8 washes, and 2 ± 7.8% (n=5) for 13 washes. Decreases in the net regulated activity is indicative of desensitization of the myofibrils to Ca 2+ , which in this method, is attributed to the depletion of regulatory units, Tm and Tn. Thirteen washes in the depletion buffer yielded the lowest net regulated activity, but not the highest activity levels. Because the best maximal activity in the presence of Ca 2+ and the smallest remaining net activity were achieved between 8 to 10 washes, and 8 was chosen as the optimal number of washes for depletion of myofibrils for all subsequent experiments.
Method for Tm-Tn Reconstitution into Depleted
Myofibrils-To assess the effects of reconstitution of exogenous Tm-Tn on the depleted myofibrils, and in order to optimize the conditions for the best reconstitution, depleted myofibrils (DM) were incubated with various concentrations of recombinant ASWT Tm-Tn. DM which had been treated with [Tm-Tn] of less than 3.6µM did not regain activity or regulation back to the level of PCM (data not shown). DM which had been treated with 4.5 to 6.8µM Tm-Tn, regained its activity in the presence of Ca 2+ and also the ability to inhibit ATPase activity in the absence of Ca Extent of Depletion and Reconstitution of ASWT and mutant Tm-In order to determine the extent of depletion and reconstitution, samples of prepared myofibrils were separated by 12.5% SDS-PAGE, and stained with Coomassie Brilliant Blue. Densitometry of Tm vs. essential light chain (ELC) was utilized to quantify the amount of Tm depleted and reconstituted. Shown in Table 1 , is the percentage of Tm remaining in DM, and the percentages of Tm in reconstituted myofibrils when compared to PCM. In order to examine the effects of the depletion and reconstitution methods on other myofibrillar proteins, myofibril samples were reduced and separated on a 4-20% TrisGlycine gradient gel (Figure 3) . Figure 3 shows that the majority of the visible TnT, Tm, TnI and TnC, were removed with the depletion process, but none of the other proteins appeared to be affected. After reconstitution, all of the Tns returned to the level of PCM. The FHC mutant Tms E180G and L185R consistently ran slightly faster than the other mutants (Figure 3 ).
Functional Effects of Tm-Tn Depletion and
Reconstitution with WT or ASWT-Myofibrillar ATPase activity assays of PCM, DM, and myofibrils which have been reconstituted with recombinant ASWT or WT were conducted to determine the effects of exogenous Tm-Tn reconstitution on the ATPase activity. Figure 5 shows that when myofibrils were depleted of their endogenous Tm-Tn, the following effects result, 1) a complete loss of inhibition, as evidenced by the linearity of the Ca 2+ induced activities at the various pCa points, and 2) a significant decrease of maximal ATPase activity when compared to the maximal ATPase activity of PCM at high [Ca 2+ ]. When the myofibrils were reconstituted with WT or ASWT Tm, 1) the maximal activity fully returned back to the level of PCM, and 2) ASWT inhibited ATPase activity approximately 50% better than WT at low [Ca 2+ ] (Figure 8 ). Therefore, ASWT was chosen for all comparisons with mutant Tms.
Functional Effects of HCM-Causing Tm
Mutations on Myofibrillar ATPase Activity-In order to determine the effects of the HCM-causing mutations on the Ca 2+ sensitivity of ATPase activity, mutant reconstituted myofibrils were prepared. Depleted myofibrils were treated with a 4.5µM mixture of various mutant Tms and wildtype Tn. The ATPase activity assays were conducted with the reconstituted myofibrils and the effects of the mutations on the maximal activity, inhibitory activity, and the Ca 2+ sensitivity of ATPase activity, was determined. Figure 6 shows that all three HCM mutations caused, 1) an increase in Ca 2+ sensitivity, over ASWT Tm, 2) no significant change in the average maximal ATPase activity at high [Ca 2+ ], and 3) a large decrease in their ability to inhibit ATPase activity at low [Ca 2+ ]. The calculated ∆pCa 50 (∆pCa 50 =pCa 50 for ASWT-pCa 50 for mutant) values are: 0.21 for E62Q, 0.40 for L185R, and 0.44 for E180G.
Functional Effects of DCM-Causing Tm
Mutations on Myofibrillar ATPase ActivityMyofibrils which have been depleted and reconstituted with DCM mutant Tms displayed an ATPase activity profile distinct from that of the HCM mutants (Figure 7 ). Both DCM-causing mutations caused a slight decrease in the Ca 2+ sensitivity, and no significant change in the average maximal ATPase activity, over ASWT Tm. Neither mutation affected the inhibition of ATPase activity. The calculated ∆pCa 50 values are: -0.19 for E40K, and -0.15 for E54K.
Effects of Depletion and Reconstitution with TmTn on the Inhibition of ATPase Activity-
Comparison of the inhibitory activity of reconstituted myofibrils has shown that there is a trend in the mutations studied (Figure 8 ). HCM mutants cause significant decreases in inhibition, while DCM mutants have no measurable effect. Although none of the reconstituted myofibrils inhibit as well as PCM, based on the normalized percentages of activities measured at low [Ca 2+ ], of 24 ± 6.5% for WT and 16 ± 3.1% for ASWT, ASWT inhibits approximately 50% better than WT.
DISCUSSION
The data presented here provide the first report of the usage of myofibrillar ATPase activity assays to assess effects of cardiomyopathy-causing mutations in Tm, utilizing a depletion/reconstitution technique. The method for selective depletion of endogenous Tm-Tn is the first method reported for its successful rapid removal from cardiac myofibrils, without the loss of other major sarcomeric proteins. Previous reports by Perry et al, of the use of low ionic strength alkaline solutions for the removal of myofibrillar proteins, required numerous days of dialysis in the depletion solutions (12) . Our present method of reconstitution of exogenous Tm-Tn back into the depleted myofibrils is effective in achieving near complete reconstitution of regulatory activity. Based on the results of the SDS-PAGE analysis, where greater than 80% of the endogenous Tm-Tn can be removed, and completely replaced with exogenous Tm-Tn (Table 1) , this method may also be suitable for the investigation of mutations in the Tn subunits. Due to the low ionic strength of the reaction buffers, used to achieve high levels of phosphate release by cardiac myofibrils (24) , the Ca 2+ sensitivities of the ATPase activity measurements for all the samples are higher than what has been reported for force development measurements on skinned muscle preparations. However, the high Ca 2+ sensitivity for PCM, agrees with what has previously been reported by our laboratory (22) . The Ca 2+ sensitivity of myofibrillar ATPase activities reported by other laboratories slightly differ from the values reported here, due to species, and reaction solution differences (25, 26) .
In the investigation of the functional effects of Tm-Tn depletion and reconstitution with WT and ASWT Tm-Tn, the results further validated the new method, and correlated with what is known for the importance of the AlanineSerine extension in bacterially expressed Tm (15, 27, 28) . Previous characterization of ASWT Tm has shown that the dipeptide extension is necessary and sufficient for bacterial expression of functional Tm, as determined by viscometry measurements and the ability to inhibit ATPase activity in actomyosin-S1 ATPase measurements, while Tm which lack the dipeptide extension simply do not function as well as ASWT (15, 27, 28 ). In the current study, when myofibrils were reconstituted with ASWT over WT, there were no significant differences in maximal ATPase activities at high [Ca 2+ ], and contrary to previous reports on the total lack of WT Tm function in the inhibition of actomyosin-S1 ATPase activities (15), myofibrils which have been reconstituted with WT Tm inhibit ATPase activity very well ( Figure 5 ). This suggests that in a more intact system, such as in myofibrils, Tm is able to bind actin and TnT, with or without the amino terminal modifications. In addition, the activity level measured for DM showed a significant decrease at high [Ca 2+ ], which returned back to normal levels when reconstituted with TmTn. This drop in maximal activity is also evident in the depletion optimizations (Figure 1) , where the maximal activities of myofibrils which have been washed in depletion buffer were all lower than PCM. These results agree with TnC's function as an activator of actomyosin-S1 ATPase activity (29) . It was previously reported by this lab that TnC plays a dual role in the regulation of muscle contraction. In the presence of Ca 2+ , TnC functions as an activator of actomyosin-S1 ATPase activity, whereas in low Ca 2+ , it has an inhibitory effect. In agreement with previous findings, without the activation or inhibition promoting regulatory units present, the basal ATPase activity is lower than the maximal of PCM, and much higher than the activity in low Ca 2+ .
The results for the investigation of the functional effects of the HCM-causing Tm mutations, is the first demonstration of a decrease in inhibition for Tm mutants. This phenomena was previously reported in our laboratory for the HCM-causing missense mutation, R145G in cardiac troponin I (25, 30) . The widely studied HCM-causing Tm mutation, Glutamic acid 180 to Glycine (E180G), was chosen as a control for the new method, based on in vitro and in vivo data reported by several other groups. In vitro studies showed that this mutation causes a significant decrease in actin binding affinity, when measured by co-sedimentation assays (31) (32) (33) . E180G also caused a loss in the stability of the Tm structure when thermal denaturation was measured by circular dichroism and differential scanning calorimetry (32, 33) .
In addition, E180G-Tm causes a decrease in thin filament motility when measured by in vitro motility assays (31, 34) . In vivo studies of transgenic mice expressing this mutation showed a severe phenotype of hypertrophy, myocardial disarray, and detrimental effects on contraction and relaxation (35, 36) . Our results for E180G correlate with what is known and briefly described above, except for the effect of the mutation on inhibition, which is a novel finding. There are several possibilities for the explanation of the loss in inhibition. One of these could be the incomplete reconstitution of Tm-Tn, but the results of the SDS-PAGE analysis show that reconstitution is nearly complete for all mutants. Another possibility for the loss of inhibition may be that the Tn is only partially active, but our results show that this cannot be the case since the same Tn was used for the ASWT and DCM mutants, which all inhibit significantly better than the HCM mutants.
A better explanation for the loss of inhibition is that the HCM mutants are not binding actin as well. It is already known for E180G, that this mutation causes large decreases in actin binding affinity, of as much as three-fold (31) (32) (33) 37) . When Tm does not bind well to actin, more myosin may bind and form strong cross bridges (1), the cycling of which, may contribute to a shift in the Ca 2+ sensitivity of ATPase activity. The ATPase activity at low [Ca 2+ ] may be one of the factors for the large increase in [Ca 2+ ] sensitivity. For every [Ca 2+ ], there would be higher amounts of total ATPase activity due to the significant amount of unregulated ATPase activities measured at low [Ca 2+ ], causing an already left shifted curve to be further shifted.
In addition to actin binding affinity, some of these mutations may affect the binding of TnT to Tm. The contribution of TnT to inhibition of muscle contraction, via Tm, in the absence of Ca 2+ is well established (38) . If the mutations are compromising TnT's ability to promote stabilization of the blocked or closed state of Tm, then cross bridges may form, accounting for the ATPase activity at low [Ca 2+ ], shown in figure 6 . Because the function of the Tn complex in muscle contraction is tightly regulated, the effects of the mutation on TnT's interaction with Tm may also affect the structure of TnC, whose main function is to bind Ca 2+ . Therefore, it is also possible that TnC's affinity for Ca 2+ may be increased, causing a decrease in the Ca 2+ off rate, and also, the cardiac relaxation rate. Correlating the outcome of these ATPase measurements to the clinical phenotypes of patients with Tm-HCM, one can speculate that the loss in inhibition, in addition to the increased Ca 2+ sensitivity, was a major contributing factor to the severe diastolic dysfunction seen in these patients.
Our results for the functional studies of the DCM-causing Tm mutations show that both mutations cause small decreases in Ca 2+ sensitivity. However, unlike previous reports on the effects of these two mutations on in vitro motility assays (39) , in the current study neither of the mutations caused significant decreases in the average maximal ATPase activity. Although a decrease in Ca 2+ sensitivity often occurs in conjunction with a decrease in maximal activity, for the same reasons discussed above, where when the Ca 2+ sensitivity of ATPase activity is decreased at every pCa point, less total ATPase activity will occur; however in the current studies, the shift in Ca 2+ sensitivity may be too small to significantly affect the maximal ATPase activity.
These distinct results for the DCM-and HCM-associated Tm mutations on muscle function correlate very well with the phenotypes observed clinically. Although it is yet not clear how the progression from pathogenic mutation to manifestation of disease phenotype occurs, it is clear that it is a progressive process, based on previous experimental studies of mouse models, which have shown that the hearts of mice harboring mutations start off phenotypically normal (40) . Subtle changes in the muscle contractile dynamics may be the trigger for remodeling processes which can lead to the clinical consequences observed in patients with cardiac dysfunction. Therefore, it is important to understand the basic structural and functional consequences of mutations in components of the contractile apparatus. To further our knowledge of muscle physiology and in order to understand the link between muscle function and mutations in Tm, the new methods described here, are currently being employed in skinned fiber preparations.
FIGURE LEGENDS
Figure 1: Maximal ATPase activity measurements of myofibrils which have been depleted of its endogenous Tm-Tn. Myofibrils were washed in depletion buffer 5 to 13 times, to remove the endogenous Tm-Tn, and the extent of depletion was compared with un-depleted myofibrils (PCM), which had 0 depletion washes. Loss of endogenous regulatory units, Tm-Tn, were assessed by the amount of ATPase activity at high(0.05mM Ca 2+ ) and low(0.05mM EGTA) [Ca 2+ ], and the fraction of net activity(activity at high [Ca 2+ ]-activity at low [Ca 2+ ]) remaining after the depletion washes. The results are the mean ± S.D. of activity measurements which have been normalized to PCM activity at high [Ca 2+ ]. The experiments were conducted the number of times shown (n), in triplicate. The Ca 2+ activated ATPase activity of wild-type reconstituted myofibrils. Myofibrils were depleted of the endogenous Tm-Tn and reconstituted with wild-type Tm with (ASWT) or without (WT) the Alanine-Serine dipeptide extension, using the steps outlined in the previous figure (Figure 4) . The activity at pCa 5.0 and pCa 9.1, of un-depleted myofibrils (PCM) was compared with that of WT and ASWT reconstituted myofibrils. Statistical analysis show that WT and ASWT both do not inhibit as well as PCM at pCa9. At pCa 5.1, only the depleted myofibril (DM) activity rate is lower than that of ASWT. + P<0.05 when compared with PCM, and *P<0.05 when compared with ASWT. Data points for each sample were fitted to the Hill plot using SigmaPlot for Windows, and the resulting average pCa 50 values were obtained from the fitted curve: PCM (6.68±0.118), WT (6.65±0.037), and ASWT (6.57±0.085). The results represent mean ± S.D. of calculated activity rates of experiments performed in triplicate, the following number of times: PCM (n=6), DM (n=6), WT (n=3), ASWT (n=6). 
